This is the FIRST live streamed only, One day professional conference discussing Cancer Pathology. We have gathered together invited speakers from around the world, who you might not otherwise have access to.
Discussing the challenges of improving cancer outcomes, including strategies for early detection and targeted treatment.
Event Description: Improving long-term survival rates in cancer remains a major global challenge. This event will bring together those involved at all stages of disease management from early detection in the GPs office to improved therapeutic interventions and disease monitoring. We will also showcase the latest in scientific research aimed at supporting this unmet clinical need. One of the major causes of death in the world is cancer. Cancer is the second most deadly disease. There are about 120 different types of cancer known to mankind. This event will highlight various aspect of cancer. This event is a platform for all the Research Scientists, oncologists, researcher scholars, professors and all those working in this field to share their research to the world of science.
We encourage questions, discussion and debate and have a relaxed atmosphere which generates maximum interaction online.
After registration you will be connected to an online networking site where you will be able to have discussions with all participants of this event, before, during and after the meeting.
Who Should Attend: All those involved in the different stages of cancer patient management, as well as research scientists. academics and pharmaceutical professionals with an interest in cancer research and treatment.
A Euroscicon live streamed event gives you access to a wider range of international speakers at a fraction of the cost of a real world event. Furthermore, you no longer have to worry about travel or accommodation expenses, or any arrangements you have which clash with our events.
Deadlines:
ORAL ABSTRACT SUBMISSION DEADLINE:-July 15th
EARLY REGISTRATION DEADLINE: July 20th
POSTER SUBMISSION DEADLINE: August 25th
Invited speakers and their talks Include:
| Talk | Speaker | Affiliation | Country |
|---|---|---|---|
| Overview of Wnt Signalling Involvement in Glioma Initiation and Progression | Professor Nives Pecina-Slaus | Medical School University of Zagreb | Croatia |
| The role of WNT signaling pathway and epithelial-mesenchymal transition in intracranial meningiomas | Anja Bukovac | Croatian Institute for Brain Research, Zagreb, Croatia | Croatia |
| Synchronous primary endometrial and ovarian carcinomas: Diagnostic challenges and prognosis | Professor Riadh Ben Temime | Department of obstetrics and gynecology; Charles Nicolle university hospital, Tunis, Tunisia | Tunisia |
| Overview of Wnt Signalling Involvement in Glioma Initiation and Progression | Professor Nives Pecina-Slaus | Laboratory of Neurooncology, Croatian Institute for Brain Research, and Department of Biology School of Medicine University of Zagreb | Croatia |
| Pathology of Neuroendocrine carcinoma of the skin (Merkel cell) | Professor Patricia Tai | University of Saskatchewan & University of Hong Kong (Honorary) | Hong Kong |
| Changes in gene structure and protein expression of DVL1, DVL2, DVL3 and transcription factors TCF1 and LEF1 in astrocytic brain tumors | Dr. Anja Kafka | Croatian Institute for Brain Research | Croatia |
A Euroscicon live streamed event gives you access to a wider range of international speakers at a fraction of the cost of a real world event. Furthermore, you no longer have to worry about travel or accommodation expenses, or any arrangements you have which clash with our events.
Advisory Board Members
| Member | Affiliation | Country |
|---|---|---|
| Associate Professor Harman Sekhon | University of Ottawa | Canada |
| Dr. Sterghios A. Moschos | University of Westminster | United Kingdom |
| Dr. David Henry | University of Pennsylvania | United States |
| Professor Rui Amaral Mendes | Case Western Reserve University | United States |
| Dr Gray Kueberuwa | Manchester Cancer Research Centre | United Kingdom |
| Dr Alice Carrier | Inserm - Institut national de la santé et de la recherche médicale | France |
Advancing pathology for cancer diagnosis, staging and prognosis has an open abstract session.
Abstracts can be submitted on any subject related to advancing pathology for cancer diagnosis.
